Similar articles for PMID: 17607041

Year	Number of Results
1950	1
1951	2
1972	1
2001	2
2002	1
2005	1
2006	1
2007	7
2009	1
2011	1
2012	3
2013	1
2014	2
2015	2
2016	1
2017	1
2018	1
2019	1
2024	0

1

The impact of urinary excretion of (18)F-labeled choline analogs.

DeGrado TR, Kwee SA, Coel MN, Coleman RE. DeGrado TR, et al. J Nucl Med. 2007 Jul;48(7):1225. doi: 10.2967/jnumed.107.040667. J Nucl Med. 2007. PMID: 17607041 Free article. No abstract available.

2

[Clinical application of fluorocholine positron emission tomography in relapsed prostate cancer].

Oelstrom M, Núñez R, Sanchez P, Sanchez-Saugar E, Garcia-Cañamaque L, Duran I. Oelstrom M, et al. Actas Urol Esp. 2012 Jul-Aug;36(7):444-6. doi: 10.1016/j.acuro.2011.11.018. Epub 2012 Jun 17. Actas Urol Esp. 2012. PMID: 22710092 Spanish. No abstract available.

3

Cancer imaging with fluorine-18-labeled choline derivatives.

Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Kwee SA, et al. Semin Nucl Med. 2007 Nov;37(6):420-8. doi: 10.1053/j.semnuclmed.2007.07.003. Semin Nucl Med. 2007. PMID: 17920349 Review.

4

[Pitfalls with 18F-choline PET/CT in patients with prostate cancer].

García Vicente AM, Núñez García A, Soriano Castrejón AM, Jiménez Londoño GA, Cordero García JM, Palomar Muñoz A. García Vicente AM, et al. Rev Esp Med Nucl Imagen Mol. 2013 Jan;32(1):37-9. doi: 10.1016/j.remn.2012.01.005. Epub 2012 Mar 27. Rev Esp Med Nucl Imagen Mol. 2013. PMID: 23177342 Spanish.

5

Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.

DeGrado TR, Baldwin SW, Wang S, Orr MD, Liao RP, Friedman HS, Reiman R, Price DT, Coleman RE. DeGrado TR, et al. J Nucl Med. 2001 Dec;42(12):1805-14. J Nucl Med. 2001. PMID: 11752077 Free article.

6

18F-choline PET/CT for initial staging of advanced prostate cancer.

Gutman F, Aflalo-Hazan V, Kerrou K, Montravers F, Grahek D, Talbot JN. Gutman F, et al. AJR Am J Roentgenol. 2006 Dec;187(6):W618-21. doi: 10.2214/AJR.05.0437. AJR Am J Roentgenol. 2006. PMID: 17114515 No abstract available.

7

Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Schuster DM, Votaw JR, Nieh PT, Yu W, Nye JA, Master V, Bowman FD, Issa MM, Goodman MM. Schuster DM, et al. J Nucl Med. 2007 Jan;48(1):56-63. J Nucl Med. 2007. PMID: 17204699 Free article.

8

A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer.

Oka S, Hattori R, Kurosaki F, Toyama M, Williams LA, Yu W, Votaw JR, Yoshida Y, Goodman MM, Ito O. Oka S, et al. J Nucl Med. 2007 Jan;48(1):46-55. J Nucl Med. 2007. PMID: 17204698 Free article.

9

Imaging of Prostate Cancer Using Fluciclovine.

Savir-Baruch B, Zanoni L, Schuster DM. Savir-Baruch B, et al. Urol Clin North Am. 2018 Aug;45(3):489-502. doi: 10.1016/j.ucl.2018.03.015. Epub 2018 Jun 15. Urol Clin North Am. 2018. PMID: 30031468 Review.

10

Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.

DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, Polascik TJ, Price DT. DeGrado TR, et al. Cancer Res. 2001 Jan 1;61(1):110-7. Cancer Res. 2001. PMID: 11196147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year